PATHWAYS TO THROMBOSIS DURING INITIAL AND RECURRENT INFECTIONS LIKE COVID AND THERAPEUTIC PLASMA EXCHANGE (TPE) 

PATHWAYS TO THROMBOSIS DURING INITIAL AND RECURRENT INFECTIONS LIKE COVID AND THERAPEUTIC PLASMA EXCHANGE (TPE) 

Recurrent deep venous thrombosis (DVT) during infectious diseases like COVID-19 happens because the virus triggers a severe systemic inflammatory and procoagulant state. [1, 2]

The mechanisms driving this increased risk are explained through Virchow’s triad (endothelial injury, hypercoagulability, and stasis) combined with specific immune responses: [1, 2]

1. Endothelial Injury and Viral Direct Invasion
2. Hypercoagulability (Overactive Clotting)
3. Venous Stasis